Oriental Carbon and Chemicals (OCCL) Q4 12/13 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 12/13 earnings summary
2 Nov, 2026Executive summary
FY13 net sales rose 4% to Rs 22,544 lakh, while PBT fell to Rs 4,004 lakh and PAT to Rs 2,738 lakh.
Insoluble Sulphur remained the core business; Phase II at Mundra began commercial production in May 2012, adding 5,500 MTpa capacity.
Financial highlights
Net revenue was Rs 22,544.07 lakh vs Rs 21,781.92 lakh; total revenue was Rs 23,032.00 lakh vs Rs 22,200.19 lakh.
EBITDA/PBIDT was Rs 6,242.57 lakh vs Rs 5,993.14 lakh; PBT was Rs 4,003.51 lakh vs Rs 4,449.79 lakh and PAT Rs 2,738.45 lakh vs Rs 3,145.76 lakh.
Finance costs increased to Rs 1,277.65 lakh from Rs 831.22 lakh; depreciation and amortisation rose to Rs 961.41 lakh from Rs 712.13 lakh.
Basic and diluted EPS was Rs 26.60 vs Rs 30.55; proposed final dividend was Rs 3/share, bringing the FY13 total dividend to 50%.
Outlook and guidance
Insoluble Sulphur sales were expected to reach optimum levels in H2 FY14 through new geographic markets and customers, despite continuing sluggish tyre demand.
Sulphuric Acid prices and Oleum prices could face pressure as increased by-product capacity at zinc and copper plants lifted regional supply.
Sulphuric Acid plant debottlenecking was planned to generate additional steam for the Dharuhera Insoluble Sulphur plant.
Latest events from Oriental Carbon and Chemicals
- Profitable growth and a ₹216 crore expansion plan advance the next capacity phase.OCCL
Q4 18/19 - COVID-19 hit FY20 results; FY21 outlook signaled lower sales and delayed expansion.OCCL
Q4 19/20 - Higher FY18 profit and expanding Insoluble Sulphur capacity underpin the growth outlook.OCCL
Q4 17/18 - Higher margins lifted PAT despite weaker sales; Mundra expansion was due in April 2017.OCCL
Q4 15/16 - Mundra expansion and Insoluble Sulphur growth drive the FY2016-17 outlook.OCCL
Q4 16/17 - FY15 profit advanced as Insoluble Sulphur demand and capacity utilization strengthened.OCCL
Q4 14/15 - FY14 growth was led by Insoluble Sulphur, with expansion prospects shadowed by SEZ uncertainty.OCCL
Q4 13/14 - FY11 profit rose as capacity expansion targeted strong Insoluble Sulphur demand.OCCL
Q4 10/11 - Revenue grew 37%, while Mundra expansion lifted Insoluble Sulphur capacity amid higher costs and market risks.OCCL
Q4 11/12